Characterization of the 5-HT7Receptor. Determination of the Pharmacophore for 5-HT7Receptor Agonism and CoMFA-Based Modeling of the Agonist Binding Site

Journal of Medicinal Chemistry
2003.0

Abstract

On the basis of a set of 20 diverse 5-HT(7) receptor agonists, the pharmacophore for 5-HT(7) receptor agonism was determined. Additionally two CoMFA models were developed, based on different alignments of the agonists. Both models show good correlations between experimental and predictive pK(i) values and show a high degree of similarity. The CoMFA fields were subsequently used to map the agonist binding site of the model of the 5-HT(7) receptor. Important roles in ligand binding are attributed to Asp162 of TM3 (interaction with a protonated nitrogen), and Thr244 of TM5 (interaction with a substituent at an aromatic moiety). Amino acid residues of the aromatic cluster of TM6 are hypothesized to play an important role in ligand binding as pi-pi stacking moieties. Agonists missing a hydrogen-bond-accepting moiety, but possessing an aromatic substituent instead, seem to bind the receptor with high affinity as well by occupying a lipophilic pocket hosted by residues of TM5 and TM6.

Knowledge Graph

Similar Paper

Characterization of the 5-HT<sub>7</sub>Receptor. Determination of the Pharmacophore for 5-HT<sub>7</sub>Receptor Agonism and CoMFA-Based Modeling of the Agonist Binding Site
Journal of Medicinal Chemistry 2003.0
Optimization of the Pharmacophore Model for 5-HT<sub>7</sub>R Antagonism. Design and Synthesis of New Naphtholactam and Naphthosultam Derivatives
Journal of Medicinal Chemistry 2003.0
5-HT 7 receptor modulators: Amino groups attached to biphenyl scaffold determine functional activity
European Journal of Medicinal Chemistry 2016.0
Electrostatic Potential Surfaces of 5-HT3R Agonists Suggest Accessory Cation–π Site Adjacent to Agonist Binding Domain
Bioorganic &amp; Medicinal Chemistry Letters 2002.0
A comprehensive study on the 5-hydroxytryptamine3A receptor binding of agonists serotonin and m-chlorophenylbiguanidine
Bioorganic &amp; Medicinal Chemistry 2009.0
Discovery of aryl-biphenyl-2-ylmethylpiperazines as novel scaffolds for 5-HT7 ligands and role of the aromatic substituents in binding to the target receptor
Bioorganic &amp; Medicinal Chemistry 2013.0
CoMFA-Based Prediction of Agonist Affinities at Recombinant D1 vs D2 Dopamine Receptors
Journal of Medicinal Chemistry 1998.0
CoMFA-Based Prediction of Agonist Affinities at Recombinant Wild Type versus Serine to Alanine Point Mutated D2 Dopamine Receptors
Journal of Medicinal Chemistry 2000.0
Affinity of aporphines for the human 5-HT2A receptor: Insights from homology modeling and molecular docking studies
Bioorganic &amp; Medicinal Chemistry 2010.0
Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties
European Journal of Medicinal Chemistry 2014.0